Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

Seqirus Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (93)
Cancellation by sponsor (27)
Prescription medicine registration (19)
Australian public assessment report (AusPar) (11)
Section 14, TGO91 consent (3)
Designation or determination (2)
Prescription medicine decision summary (2)
Prescription medicine evaluation (2)
Cancellation or suspension (1)

Date

2026 (3)
2025 (15)
2024 (3)
2023 (6)
2022 (8)
2021 (6)
2020 (28)
2019 (12)
2018 (19)
2017 (6)
2016 (3)
2015 (1)
2014 (3)
2012 (1)
2011 (7)
2010 (3)
2009 (5)
2008 (1)
2006 (3)
2005 (1)
2004 (4)
2003 (1)
2002 (1)
2000 (13)
1998 (3)
1991 (4)

Search

Sponsor content

160 result(s) found, displaying 61 to 70

FLUVAX inactivated influenza vaccine (split virion) thiomersal free 0.5mL injection syringe Cancelled under Section 30(1)(c) of the Act

18 December 2020

Cancellation by sponsor

Requested by Seqirus Pty Ltd
AGRIPPAL inactivated influenza (surface antigen) vaccine injection pre-filled syringe (with needle) Cancelled under Section 30(1)(c) of the Act

18 December 2020

Cancellation by sponsor

Requested by Seqirus Pty Ltd
FLUVAX influenza vaccine (split virion) thiomersal free 0.5 mL injection syringe Cancelled under Section 30(1)(c) of the Act

18 December 2020

Cancellation by sponsor

Requested by Seqirus Pty Ltd
Aflunov(r) Prepandemic Influenza Vaccine, H5N1 (surface antigen, inactivated, adjuvanted) 0.5mL pre-filled syringe Cancelled under Section 30(1)(c) of the Act

18 December 2020

Cancellation by sponsor

Requested by Seqirus Pty Ltd
Prepandemic Influenza Vaccine H5N1 (surface antigen, inactivated, adjuvanted) Novartis Vaccines and Diagnostics 0.5mL pre-filled syringe Cancelled under Section 30(1)(c) of the Act

18 December 2020

Cancellation by sponsor

Requested by Seqirus Pty Ltd
AGRIPPAL inactivated influenza (surface antigen) vaccine injection pre-filled syringe (without needle) Cancelled under Section 30(1)(c) of the Act

18 December 2020

Cancellation by sponsor

Requested by Seqirus Pty Ltd
OPTAFLU inactivated influenza virus vaccine (surface antigens), prepared in cell cultures injection pre-filled syringe (without needle) Cancelled under Section 30(1)(c) of the Act

18 December 2020

Cancellation by sponsor

Requested by Seqirus Pty Ltd
OPTAFLU inactivated influenza virus vaccine (surface antigens), prepared in cell cultures injection pre-filled syringe (with needle) Cancelled under Section 30(1)(c) of the Act

18 December 2020

Cancellation by sponsor

Requested by Seqirus Pty Ltd
IKERVIS (Seqirus Pty Ltd)

3 December 2020

Prescription medicine registration

Active ingredients: ciclosporin.
H5N1 influenza vaccine (303978)

6 June 2018

ARTG

Australian Register of Therapeutic Goods (ARTG) information for H5N1 influenza vaccine.

Pages

First page
Previous page
…
Page 3
Page 4
Page 5
Page 6
Current page 7
Page 8
Page 9
Page 10
Page 11
…
Next page
Last page

Is there anything wrong with this page?

Help us improve

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.